Literature DB >> 2790218

Alcohol-induced bone marrow damage: status before and after a 4-week period of abstinence from alcohol with or without disulfiram. A randomized bone marrow study in alcohol-dependent individuals.

G Casagrande1, F Michot.   

Abstract

The investigation described in this paper has confirmed the existence of alcohol-induced bone marrow damage as a nosological entity in alcohol-dependent individuals. In our patients total abstinence from alcohol without disulfiram or similar drugs led to reversal of the pathological findings in peripheral blood and in bone marrow. In patients undergoing detoxification while taking disulfiram, on the other hand, the pathological bone marrow findings, especially erythropoiesis associated with impaired iron utilization, persisted. The metabolic pathway of disulfiram is discussed. It is probably justifiable to assume that the toxin responsible for alcohol-induced bone marrow damage is the ethanol metabolite acetaldehyde. The persistence of erythropoiesis with impaired iron utilization during abstinence from alcohol and treatment with disulfiram is also of importance in differential diagnosis from the myelodysplastic syndrome (MDS), and especially from refractory anaemia with ring sideroblasts (RARS). For this reason, where the situation is unclear, it is essential that a diagnosis of MDS be supported by specific investigations such as cell cultures, cytogenetic analyses, etc. It is the first time that the toxic, alcohol-like-effect of disulfiram on haematopoiesis is discussed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2790218     DOI: 10.1007/bf00320853

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  24 in total

1.  Vitamin B6 metabolism in chronic alcohol abuse. Pyridoxal phosphate levels in plasma and the effects of acetaldehyde on pyridoxal phosphate synthesis and degradation in human erythrocytes.

Authors:  L Lumeng; T K Li
Journal:  J Clin Invest       Date:  1974-03       Impact factor: 14.808

2.  Circulating cytotoxic protein generated after ethanol consumption: identification and mechanism of reaction with cells.

Authors:  S N Wickramasinghe; B Gardner; G Barden
Journal:  Lancet       Date:  1987-07-18       Impact factor: 79.321

3.  [Hematologic changes following chronic alcoholism].

Authors:  H J Sanft; K Schulz
Journal:  Folia Haematol Int Mag Klin Morphol Blutforsch       Date:  1983

Review 4.  Hematologic complications of alcoholism: overview.

Authors:  N Colman; V Herbert
Journal:  Semin Hematol       Date:  1980-07       Impact factor: 3.851

Review 5.  Vacuolated nucleated bone marrow cells in alcoholism.

Authors:  P R McCurdy; C E Rath
Journal:  Semin Hematol       Date:  1980-04       Impact factor: 3.851

6.  Macrocytosis in alcohol-related liver disease: its value for screening.

Authors:  M Y Morgan; M E Camilo; W Luck; S Sherlock; A V Hoffbrand
Journal:  Clin Lab Haematol       Date:  1981

Review 7.  [Aplastic anemia].

Authors:  B Speck
Journal:  Schweiz Med Wochenschr       Date:  1986-10-25

8.  [Diagnosis of alcoholism in repeatedly intoxicated motorists. A study of 100 evaluations].

Authors:  F Michot; P Blum; A Schenker
Journal:  Schweiz Med Wochenschr       Date:  1984-10-20

9.  Mechanism of inhibition of granulopoiesis by ethanol.

Authors:  P S Imperia; G Chikkappa; P G Phillips
Journal:  Proc Soc Exp Biol Med       Date:  1984-02

Review 10.  Nutritional anemia in alcoholism.

Authors:  J Lindenbaum; M J Roman
Journal:  Am J Clin Nutr       Date:  1980-12       Impact factor: 7.045

View more
  2 in total

1.  Alcohol consumption and risk of myelodysplastic syndromes: A meta-analysis of epidemiological studies.

Authors:  Jie Jin; Mengxia Yu; Chao Hu; Li Ye; Lili Xie; Feifei Chen; Zhengping Zhuang; Hongyan Tong
Journal:  Mol Clin Oncol       Date:  2014-08-07

2.  Factors Influencing the Successful Isolation and Expansion of Aging Human Mesenchymal Stem Cells.

Authors:  Pan Pan Chong; Lakshmi Selvaratnam; Azlina A Abbas; Tunku Kamarul
Journal:  Open Life Sci       Date:  2018-08-21       Impact factor: 0.938

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.